Mitochondrial function in thoracic aortic aneurysms
View / Open Files
Authors
Bennett, MR
Yu, Emma
Foote, kirsty
Publication Date
2018-11-01Journal Title
Cardiovascular Research
ISSN
0008-6363
Publisher
Oxford University Press
Type
Article
Metadata
Show full item recordCitation
Bennett, M., Yu, E., & Foote, k. (2018). Mitochondrial function in thoracic aortic aneurysms. Cardiovascular Research https://doi.org/10.1093/cvr/cvy180
Abstract
Mitochondria contain multiple copies of mitochondrial DNA (mtDNA) that encode ribosomal and transfer RNAs and many essential proteins required for oxidative phosphorylation. Mitochondria are essential for generation of ATP, but also generate reactive oxygen species (ROS) as a by-product of the electron transport chain. Oxidative damage to mitochondrial DNA induces respiratory chain dysfunction, resulting in reduced ATP synthesis and further increased ROS generation. The reduced mitochondrial respiration may be accompanied by increased glycolysis and increased lactate production, and these changes can be detected by reduced oxygen consumption and increased extracellular pH of tissues or cultured cells.
Mitochondrial dysfunction leading to reduced mitochondrial respiration has been implicated in both normal vascular ageing and a variety of cardiovascular diseases,, including atherosclerosis, heart failure, and aneurysm formation. For example, reduced mitochondrial DNA (mtDNA) copy number, mitochondrial respiration and expression of specific electron transport chain complexes has been shown in vascular smooth muscle cells (VSMCs) derived from human atherosclerotic plaques1-3. Mitochondriogenesis and mitophagy are also important regulators of mitochondrial health and number. ROS induce VSMC mitophagy, and similarly plaque VSMCs show increased mitophagy compared with normal arterial VSMCs2.
Keywords
Animals, Aorta, Aortic Aneurysm, Thoracic, Extracellular Matrix Proteins, Mice, Mitochondria
Sponsorship
This work was supported by British Heart Foundation (BHF) grants PG/14/69/31032 and RG/13/14/30314, the National Institute for Health Research Cambridge Biomedical Research Centre, the BHF Centre for Research Excellence, the Academy of Medical Sciences.
Funder references
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (PG/16/11/32021)
British Heart Foundation (PG/16/63/32307)
British Heart Foundation (CH/2000003)
British Heart Foundation (PG/16/24/32090)
British Heart Foundation (None)
Identifiers
External DOI: https://doi.org/10.1093/cvr/cvy180
This record's URL: https://www.repository.cam.ac.uk/handle/1810/279837
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk